Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 March 1999

Retrospective and prospective analysis of selected factors influencing the development of diabetic nephropathy

Maryna Krawczuk-Rybak, Jadwiga Peczyńska, Mirosława Urban

Med Sci Monit 1999; 5(2): CR289-295 :: ID: 505136

Abstract

The aim of study was to identyfy factors preceding and influencing further development of diabetic nephropathy,from normo- to microalbuminuria. Retrospective analysis was carried out in the group of 15 young subjects with diabetes type 1 aged mean 16.6 years, SD=1.34, and with persistent microalbuminuria which appeared in the age mean 14.9 years, SD=1.6 (i.e. in the period '-3', '-2', '-1' years preceding appearance of permanent microalbuminuria), and in the moment of its manifestation ('0'). Prospective evaluation of the following indices was also carried out (about 2 years after appearance of microalbuminuria -'+1'): body mass index (BMI), arterial pressure values, 24-hour doses of insulin/kg of body mass, glycemic control (HbA1c), lipid balance. The control group included 13 patients of approximate age with diabetes of approximate duration without symptoms of microangiopathy.
Results: 1. Systolic arterial pressure was higher in the examined group as compared to the control group in the time of manifestation of microalbuminuria ('0') and diastolic arterial pressure - in the period '-3'. The analysis did not show differences in other periods. 2. Values of HbA1c and 24-hr dose of insulin/kg of body mass were higher in all periods of the analysis. 3. No differences in BMI were observed. 4. Values of total cholesterol did not show differences, but values of triglycerides were higher in retrospective analysis.
Conclusion: Appearance of permanent microalbuminuria is preceded by long-term incorrect glycemic control, administration of higher doses of insulin and tendency to higher values of triglycerides.

Keywords: dyslipidaemia, diabetic nephropathy, insulin-dependent diabetes

Add Comment 0 Comments

Editorial

01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315

0:00

In Press

Clinical Research  

Trust and Support for Cancer Research Biobanks: Insights from Cancer Patients in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.944263  

Clinical Research  

Morphological and Dimensional Analysis of the Nasopalatine Canal: Insights from Cone-Beam Computed Tomograp...

Med Sci Monit In Press; DOI: 10.12659/MSM.944424  

Clinical Research  

Hemorrhagic Cysts in the Pancreas: Risk Factors, Treatment, and Outcomes – Insights from a Single-Center Study

Med Sci Monit In Press; DOI: 10.12659/MSM.941955  

Clinical Research  

Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Managem...

Med Sci Monit In Press; DOI: 10.12659/MSM.944063  

Most Viewed Current Articles

14 Dec 2022 : Clinical Research   1,421,178

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

17 Jan 2024 : Review article   1,355,487

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   690,090

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial   50,113

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750